Ablation of Typical Right Atrial Flutter

Launched by HARTFORD HOSPITAL · Mar 2, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new way to treat a heart condition called typical atrial flutter. Currently, doctors usually perform a procedure called ablation through the groin to help patients maintain a normal heart rhythm. This trial is exploring whether doing the same procedure through the arm is safe and effective. The researchers will compare recovery times, success rates, and any complications between the two methods. They hope that using the arm might lead to quicker recovery and fewer issues after the procedure.

To be eligible for this trial, participants should be between 65 and 74 years old, weigh at least 110 pounds, and have been referred for atrial flutter ablation. They must also be able to give consent to participate. If someone joins the study, they can expect to undergo the ablation procedure and then be monitored for recovery and heart rhythm over the next year. The trial is currently looking for volunteers, and it aims to provide valuable information that could improve treatment options for patients with atrial flutter in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Referred to the EP lab for typical right atrial flutter ablation as an outpatient
• • Bodyweight of 50Kg (110 lb) or above
• • Documented typical atrial flutter by 12 lead EKG or telemetry
• Exclusion Criteria:
• • Bodyweight less than 50 Kg
• • Inability to provide consent
• • Presence of pacemaker or defibrillator with transvenous leads
• • Inpatient admission